Nanxi Li
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Extracellular vesicles in the tumor microenvironment: Diverse origins, multifaceted functions, and emerging therapeutic opportunities.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 06, 2026
Macrophagic Sclerostin Loop2-ApoER2 Interaction Required by Sclerostin for Cardiovascular Protective Action.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 07, 2025
Osteoblastic sclerostin loop3-LRP4 interaction required by sclerostin to inhibit bone formation.
Journal: Bone research
Published: February 06, 2025
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity.
Journal: Nature communications
Published: March 16, 2024
Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives.
Journal: Journal of orthopaedic translation
Published: December 28, 2023
The roles of hepatokine and osteokine in liver-bone crosstalk: Advance in basic and clinical aspects.
Journal: Frontiers in endocrinology
Published: January 21, 2023
A Rapid Protocol for Direct Isolation of Osteoclast Lineage Cells from Mouse Bone Marrow.
Journal: Bio-protocol
Published: September 30, 2021
Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation.
Journal: Nature communications
Published: May 31, 2021
Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice.
Journal: Theranostics
Published: May 26, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026